Based on the newest company shareholding disclosures, the Authorities of Singapore at present holds 61 listed firms, with a complete portfolio worth exceeding Rs. 2.36 lakh crore, as per sources.
In March 2025, the Authorities of Singapore added three new shares to its portfolio
With a market cap of Rs. 85,490.2 crores, the shares of Asia’s first and the world’s quickest Inventory Trade, with a velocity of 6 microseconds, moved down by practically 0.7 % on BSE to shut at Rs. 6,315 on Friday.
Based on the March 2025 shareholding knowledge, the Authorities of Singapore has added BSE to its portfolio, buying 18,63,561 fairness shares, which symbolize a 1.38 % stake within the firm.
In Q3 FY25, the corporate’s income from operations elevated by round 95.3 % YoY to Rs. 832 crores, whereas the online revenue grew by practically 106.6 % YoY to Rs. 219 crores.
BSE (Bombay Inventory Trade) Restricted is engaged in offering a capital-raising platform and a platform for buying and selling in fairness, debt devices, fairness derivatives, foreign money derivatives, rate of interest derivatives, mutual funds, and inventory lending and borrowing. It additionally has a platform for buying and selling in equities of small and medium enterprises (SME).
With a market cap of Rs. 11,162.5 crores, the shares of India’s largest eye care service chain by income from operations for FY24 moved down by practically 3.4 % on BSE to shut at Rs. 353.2 on Friday.
As of March 2025, the shareholding sample, the Authorities of Singapore has added Dr. Agarwals Well being Care Restricted in its portfolio, holding 2,04,85,625 fairness shares, accounting for a 6.49 % stake within the firm.
In Q3 FY25, the corporate’s income from operations elevated by round 29.4 % YoY to Rs. 431 crores, whereas the online revenue grew by practically 13 % YoY to Rs. 28 crores.
Dr. Agarwal’s Well being Care Restricted is engaged in offering end-to-end complete eye care companies, together with cataract, refractive and different surgical procedures; consultations, diagnoses and non-surgical remedies; and sells opticals, contact lenses and equipment, and eye care associated pharmaceutical merchandise.
With a market cap of Rs. 42,824.2 crores, the inventory moved up by practically 1 % on BSE to shut at Rs. 704.7 on Friday. As of March 2025, the shareholding sample, the Authorities of Singapore has added Hexaware Tech to its portfolio, holding practically 1.02 crore fairness shares, accounting for a 1.69 % stake within the firm.
In This autumn FY25, the corporate’s income from operations elevated by round 17 % YoY to Rs. 3,208 crores, whereas the online revenue grew by practically 17 % YoY to Rs. 327 crores.
Hexaware Applied sciences Restricted is concerned in info expertise consulting, software program growth, enterprise course of companies (BPS), knowledge and AI, cloud, Digital IT operations, and enterprise platforms.
Written by Shivani Singh
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of monetary losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer should not answerable for any losses prompted on account of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
